Mon, September 27, 2010
[ Mon, Sep 27th 2010 ] - Market Wire
Wellstar Announces New Website
Sun, September 26, 2010
Sat, September 25, 2010
Fri, September 24, 2010
Thu, September 23, 2010
Wed, September 22, 2010
Tue, September 21, 2010
Mon, September 20, 2010
Fri, September 17, 2010
Thu, September 16, 2010
Wed, September 15, 2010
[ Wed, Sep 15th 2010 ] - Market Wire
Qtrax Beta Available in India
Tue, September 14, 2010
Mon, September 13, 2010
Sun, September 12, 2010
Fri, September 10, 2010
Thu, September 9, 2010
Wed, September 8, 2010
Tue, September 7, 2010
Sat, September 4, 2010
[ Sat, Sep 04th 2010 ] - Market Wire
Transdel Pharmaceuticals
Fri, September 3, 2010
[ Fri, Sep 03rd 2010 ] - Market Wire
Transdel Pharmaceuticals

Celera to Webcast Its Presentation at the UBS Global Life Sciences Conference


//health-fitness.news-articles.net/content/2010/ .. -at-the-ubs-global-life-sciences-conference.html
Published in Health and Fitness on Tuesday, September 14th 2010 at 13:30 GMT by Market Wire   Print publication without navigation


ALAMEDA, Calif.--([ BUSINESS WIRE ])--Celera Corporation (NASDAQ:CRA) announced today that it will webcast its presentation at the UBS Global Life Sciences Conference on Tuesday, September 21, 2010. The live webcast is scheduled to begin at 2:30 pm ET when Kathy Ordoez, Chief Executive Officer of Celera, will provide an overview of the Companya™s business.

Interested parties may access the live webcast and replay by visiting the Media and Investors section of the Celera website at [ www.celera.com ]. It is suggested that participants access the webcast 15 minutes before the start of the live broadcast. The webcast replay will be archived on the Presentations page of the Media and Investors section of the website.

About Celera

Celera is a healthcare business delivering personalized disease management through a combination of products and services incorporating proprietary discoveries. Berkeley HeartLab, a subsidiary of Celera, offers services to predict cardiovascular disease risk and improve patient management. Celera also commercializes a wide range of molecular diagnostic products through Abbott and has licensed other relevant diagnostic technologies developed to provide personalized disease management in cancer and liver diseases. Information about Celera Corporation, including reports and other information filed by the Company with the Securities and Exchange Commission, is available at [ http://www.celera.com ].

Copyright© 2010. Celera Corporation. All Rights Reserved. Celera is a registered trademark of Celera Corporation or its subsidiaries in the U. S. and/or certain other countries.


Publication Contributing Sources